Anticancer Effects of Mesothelin-Targeted Immunotoxin Therapy Are Regulated by Tyrosine Kinase DDR1

Title
Anticancer Effects of Mesothelin-Targeted Immunotoxin Therapy Are Regulated by Tyrosine Kinase DDR1
Authors
Keywords
-
Journal
CANCER RESEARCH
Volume 76, Issue 6, Pages 1560-1568
Publisher
American Association for Cancer Research (AACR)
Online
2016-01-12
DOI
10.1158/0008-5472.can-15-2401

Ask authors/readers for more resources

Find Funding. Review Successful Grants.

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started